EUR 8.4
(-1.19%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 4.5 Million EUR | 542.86% |
2022 | 700 Thousand EUR | -73.08% |
2021 | 2.6 Million EUR | -86.39% |
2020 | 19.1 Million EUR | -11.16% |
2019 | 21.5 Million EUR | -21.53% |
2018 | 27.4 Million EUR | -51.42% |
2017 | 56.4 Million EUR | -2.76% |
2016 | 58 Million EUR | 89.54% |
2015 | 30.6 Million EUR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 700.00 EUR | -39.13% |
2024 Q2 | 700.00 EUR | 0.0% |
2023 Q2 | 1100.00 EUR | 0.0% |
2023 Q1 | 1100.00 EUR | -83.46% |
2023 Q4 | 1150.00 EUR | 91.67% |
2023 Q3 | 600.00 EUR | -45.45% |
2023 FY | 1 Million EUR | 42.86% |
2022 Q1 | 400.00 EUR | 0.0% |
2022 Q2 | 400.00 EUR | 0.0% |
2022 Q3 | 6650.00 EUR | 1562.5% |
2022 Q4 | 6650.00 EUR | 0.0% |
2022 FY | 700 Thousand EUR | -73.08% |
2021 Q2 | 750.00 EUR | 0.0% |
2021 FY | 2.6 Million EUR | -86.39% |
2021 Q1 | 750.00 EUR | -98.42% |
2020 Q1 | 300.00 EUR | -93.75% |
2020 FY | 19.1 Million EUR | -11.16% |
2020 Q4 | 47.45 Thousand EUR | 3.27% |
2020 Q2 | 300.00 EUR | 0.0% |
2020 Q3 | 45.94 Thousand EUR | 15216.33% |
2019 Q1 | 600.00 EUR | -95.8% |
2019 Q4 | 4800.00 EUR | 0.0% |
2019 Q2 | 600.00 EUR | 0.0% |
2019 FY | 21.5 Million EUR | -21.53% |
2019 Q3 | 4800.00 EUR | 700.0% |
2018 Q2 | 11.65 Thousand EUR | 0.0% |
2018 Q3 | 14.29 Thousand EUR | 22.74% |
2018 Q4 | 14.29 Thousand EUR | 0.0% |
2018 FY | 27.4 Million EUR | -51.42% |
2018 Q1 | 11.65 Thousand EUR | -71.72% |
2017 FY | 56.4 Million EUR | -2.76% |
2017 Q4 | 41.19 Thousand EUR | 0.0% |
2017 Q3 | 41.19 Thousand EUR | 145.23% |
2017 Q2 | 16.8 Thousand EUR | 0.0% |
2017 Q1 | 16.8 Thousand EUR | -37.78% |
2016 Q1 | 21.15 Thousand EUR | -99.85% |
2016 FY | 58 Million EUR | 89.54% |
2016 Q4 | 27 Thousand EUR | 0.0% |
2016 Q3 | 27 Thousand EUR | 27.66% |
2016 Q2 | 21.15 Thousand EUR | 0.0% |
2015 FY | 30.6 Million EUR | 0.0% |
2015 Q2 | 7.65 Million EUR | 0.0% |
2015 Q1 | 7.65 Million EUR | 0.0% |
2015 Q4 | 14.5 Million EUR | 89.54% |
2015 Q3 | 7.65 Million EUR | 0.0% |
2014 Q4 | 7.65 Million EUR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
AB Science S.A. | 14.01 Million EUR | 67.894% |
Boiron SA | 317.27 Million EUR | 98.582% |
Ipsen S.A. | 1.91 Billion EUR | 99.766% |
Vetoquinol SA | 217.11 Million EUR | 97.927% |